Search

everythinglearnresearchcommunity

for

Search:↓

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

The study found that the most common repigmentation pattern in children with vitiligo is a combination of patterns, with a new medium spotted pattern identified.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Hair transplantation can effectively treat stable eyebrow hair loss in alopecia areata patients.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Most vitiligo patients in Makkah are young women, often with family history and thyroid issues.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Microneedling with triamcinolone helps hair regrowth in ophiasis alopecia areata.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Latanoprost is more effective than minoxidil for treating alopecia areata.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

NB-UVB phototherapy is an effective and safe treatment for vitiligo, especially on hands and feet, and can be improved with tacrolimus.

A woman with multiple autoimmune diseases showed improvement in hair loss but not in skin discoloration after treatment.

PRP is popular in aesthetic treatments but its effectiveness and safety are still questioned.

Fire Needle Therapy may help bring back skin color in vitiligo by affecting cell growth signals.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.